Lepromatous leprosy: dapsone resistance.
作者信息
Barrett D F
出版信息
Proc R Soc Med. 1976 Jun;69(6):391-2. doi: 10.1177/003591577606900606.
Abstract
摘要
相似文献
1
Lepromatous leprosy: dapsone resistance.瘤型麻风：氨苯砜耐药性。
Proc R Soc Med. 1976 Jun;69(6):391-2. doi: 10.1177/003591577606900606.
2
Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.B663 [G 30 320, 氯法齐明（盖吉公司生产），麻风宁] 给药对三组麻风瘤型和界线类麻风患者的影响。
Int J Lepr Other Mycobact Dis. 1974 Jul-Sep;42(3):276-88.
3
Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.利福平、氯法齐明和氨苯砜联合多药疗法治疗多菌型麻风病例的评估。
Indian J Lepr. 1984 Jan-Mar;56(1):78-85.
4
Combined clofazimine- and dapsone-resistant leprosy. A case report.氯法齐明和氨苯砜联合耐药性麻风病。病例报告。
Int J Lepr Other Mycobact Dis. 1986 Sep;54(3):389-91.
5
6
Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Int J Lepr Other Mycobact Dis. 1974 Oct-Dec;42(4):416-418.
7
The chemotherapy of leprosy. Part 1.麻风病的化学疗法。第1部分。
Int J Lepr Other Mycobact Dis. 1990 Dec;58(4):704-16.
8
[Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
Zhonghua Yi Xue Za Zhi. 1987 Jan;67(1):1-3.
9
Transformation from lepromatous to borderline leprosy under clofazimine therapy.
Lepr India. 1976 Apr;48(2):172-6.
10
Management of sulphone-resistant lepromatous leprosy.
Lepr Rev. 1977 Jun;48(2):127-8. doi: 10.5935/0305-7518.19770015.
本文引用的文献
1
RED AND BLACK PIGMENTATION DEVELOPING DURING TREATMENT OF LEPROSY WITH 'B 663'.
Lepr Rev. 1965 Jan;36:17-20. doi: 10.5935/0305-7518.19650005.
2
Patterns of disintegration of the tarsus in the anaesthetic foot.麻醉足部跗骨的解体模式。
J Bone Joint Surg Br. 1966 Feb;48(1):4-16.
3
Tarsal bone disintegration in leprosy.
J Bone Joint Surg Br. 1971 Nov;53(4):688-95.
Zotero 插件